Search
for
Sort by
Research 151–180 of 1000+
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Absorption sites of orally administered drugs in the small intestine
- Safety of testosterone use in women
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Herbal Treatment for Dermatologic Disorders
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Thrombocytopenia and Leukopenia Associated with Itraconazole
- Liver Cirrhosis and Circadian Rhythm
- Treatment of Hair Loss
- Update on the dermatologic use of systemic glucocorticosteroids
- ADVANCES IN PSORIASIS THERAPY
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Treatment of hyperandrogenism in women
- Drug-induced acne
- Oral medications for central serous chorioretinopathy: a literature review
- Current management strategies for cutaneous T-cell lymphoma
- Sdr16c5 and Sdr16c6 control a dormant pathway at a bifurcation point between meibogenesis and sebogenesis
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Effective holistic characterization of small molecule effects using heterogeneous biological networks
- Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling
- The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- The connection of 5-alpha reductase inhibitors to the development of depression
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis